BioMed Research International

Growth Abnormalities of Fetuses and Infants


Status
Published

Lead Editor

1University of Padua, Padua, Italy

2University of Cagliari, Cagliari, Italy

3University of Rome Tor Vergata, Roma, Italy

4University of Minnesota, Minneapolis, USA


Growth Abnormalities of Fetuses and Infants

Description

This special issue will focus on an important topic for perinatologists, neonatologists, pediatricians, biologists, and engineers.

Growth abnormalities (either growth restriction or large for gestational age) during perinatal and postnatal life are a hot topic issue, since they are often linked to alteration of uterine environment caused by placental insufficiency, maternal metabolic syndrome, and in general under- or overnutrition of the fetus. These fetal abnormalities account for the leading causes of perinatal morbidity and mortality. Moreover, under the hypothesis of developmental origin of adult diseases, they bear consequences in later life, programming the infant physiology for a higher risk of noncommunicable diseases, cardiovascular adult diseases, and neurodevelopment delay.

There is an increased evidence of the link between intrauterine and perinatal alterations and adult diseases. Although the main focus so far has been the timing of delivery and follow-up, the study of the pathophysiology and of possible recovery is of paramount importance and needs the contributions of physicians from several fields, biologists, bioinformaticians, and engineers.

This special issue will focus on several aspects of intrauterine growth abnormalities and their follow-ups.

Potential topics include but are not limited to the following:

  • Intrauterine growth restriction
  • Fetal consequences of diabetes and gestational diabetes
  • Cardiovascular programming
  • Neurodevelopmental delay
  • Fetal and neonatal imaging and imaging biomarkers
  • Omics studies in fetal-neonatal growth abnormalities
  • Recovery strategies, therapies, and prevention
  • Maternal dietary and lifestyles effects in IUGR and LGA

Articles

  • Special Issue
  • - Volume 2017
  • - Article ID 2746471
  • - Review Article

Scientific Evidence for Different Options for GDM Screening and Management: Controversies and Review of the Literature

Claudia Caissutti | Vincenzo Berghella
  • Special Issue
  • - Volume 2017
  • - Article ID 2837027
  • - Research Article

Apolipoprotein E Genotype in Very Preterm Neonates with Intrauterine Growth Restriction: An Analysis of the German Neonatal Network Cohort

Stephen Norda | Tanja K. Rausch | ... | Ulrich Pecks
  • Special Issue
  • - Volume 2017
  • - Article ID 1746146
  • - Research Article

Care-Related and Maternal Risk Factors Associated with the Antenatal Nondetection of Intrauterine Growth Restriction: A Case-Control Study from Bremen, Germany

Sinja Alexandra Ernst | Tilman Brand | ... | Hajo Zeeb
  • Special Issue
  • - Volume 2017
  • - Article ID 6073167
  • - Review Article

Do miRNAs Play a Role in Fetal Growth Restriction? A Fresh Look to a Busy Corner

Benito Chiofalo | Antonio Simone Laganà | ... | Salvatore Giovanni Vitale
  • Special Issue
  • - Volume 2017
  • - Article ID 1953076
  • - Research Article

First-Trimester Crown-Rump Length and Embryonic Volume of Fetuses with Structural Congenital Abnormalities Measured in Virtual Reality: An Observational Study

L. Baken | B. Benoit | ... | N. Exalto
  • Special Issue
  • - Volume 2017
  • - Article ID 3723879
  • - Research Article

Suspected Fetal Growth Restriction at 37 Weeks: A Comparison of Doppler and Placental Pathology

William M. Curtin | Karmaine A. Millington | ... | Serdar H. Ural
BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision110 days
Acceptance to publication24 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.